我的账户 7×24小时客服热线:400-829-7929 语言:
热门产品: 人参皂苷Rh2,人参皂苷Rg3,胡萝卜苷, 木犀草苷
产品分类
在线咨询
联系电话:
销售:
400-829-7929(7*24小时)
028-82633860
028-82633397 
028-
82633165
技术服务和产品定制:
028-82633987
在线服务:  
沈帅 
文静  点击这里给我发消息
贺丹丹  
点击这里给我发消息
      
文献信息

Effect of shikonin on multidrug resistance in HepG2: The role of SIRT1

期刊名:Pharmaceutical Biology
文献编号:
文献地址: http://www.tandfonline.com/doi/abs/10.3109/13880209.2014.952836#.VgI-j_nvPIU
发表日期:04 Dec 2014


Yong-Dong Jin, Yi Ren, Ming-Wei Wu, Ping Chen & Jin Lu

Abstract

Context: Overexpression of SIRT1 is considered to enhance the resistance of HepG2 cells to irradiation. Shikonin, a naturally occurring naphthoquinone compound, displays anticancer effects and circumvents cancer drug resistance.

Objectives: This study investigated the MDR reversal effect of shikonin induced by the overexpression of SIRT1.

Materials and methods: The overexpression of SIRT1 in HepG2 cells was established by lentivirus infection. Five days after transduction, real-time quantitative polymerase chain reaction and western blotting were used to detect the expression of SIRT1 and MDR1/P-gp. Drug resistance was also evaluated by flow cytometry after rhodamine-123 staining. On day 5, the multidrug resistance cells were treated by shikonin (10?7, 10?6, and 10?5 μmol/L) one time. The cell viability was detected by the MTT assay, 

shikonin (SNK, Chengdu Biopurify Phytochemicals Ltd, Chengdu, China)

相关产品